Logo

Robert Gentleman

Apr 02, 2015

Consumer genetics firm 23andMe has appointed Robert Gentleman, formerly of Genentech, as its VP of computational biology.

The company recently announced it would launch a therapeutic division led by Richard Scheller, who was executive VP of research and early development at Genentech. Scheller is slated to join 23andMe at the start of April as chief science officer and the head of the therapeutics division.

Gentleman will work with Scheller employing data analytics and theoretical models to pinpoint trends that can inform drug discovery and development. Before joining 23andMe, Gentleman was senior director of bioinformatics and computational biology at Genentech. Prior to that he was head of the computational biology department at the Fred Hutchinson Cancer Research Center, as well as a professor at Harvard University, the University of Auckland, and the University of Waterloo.

Breaking News
The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.